Junior Investigator Intensive Program
  • Junior Investigator Intensive Program

    APPLICATION
  • Sections Overview

    • Basic Information
    • Demographics
    • Application Documents
  • Basic Information


  • Demographics

    The following demographic questions are optional, and related to the USDeN's commitment to diversity and inclusion


  • The USDeN is committed to providing opportunities to develop research careers and improve participation for individuals from groups demonstrated to have low representation in the biomedical, behavioral, clinical and social science, and to fostering diversity. 

    NIH definition of underrepresented populations

  • Application Documents

    Please upload career plan, biosketch, and mentor letter as one PDF file
  • Career Plan (up to 250 words for each of 3 sections): Please describe 1) your reasons for pursuing this opportunity; 2) your background and prior experiences that prepare you for a program in deprescribing research; 3) how the program will facilitate your research and career development goals. 

    Updated NIH-Style Biosketch:  We recognize that applicants are still early in their careers and often will not yet have made extensive contributions to the scientific literature or received external funding for research.  Please use the NIH Format to submit your biosketch.

    Mentor Letter:  Letter of support from a faculty mentor (1 page maximum). This letter should address why this meeting would be beneficial to your career development or, for later stage investigators, how this will help with your current career goals.

    Abstract (Optional, 300 words): Please include a scientific abstract up to 300 words, including sections on introduction/background, methods, results, and conclusions. This may include prior or ongoing work you have done on a topic broadly related to deprescribing or plans for a deprescribing-related project you would be interested in pursing during your time in the JII program. If you are describing ongoing or future work that does not yet have results, feel free to omit the results section. Please note that you abstract does not need to directly address deprescribing, but can address related topics such as medication use, attitudes towards care, health system redesign for older adults, or any number of other topics. 

    Travel and Accommodations Support:  Support is available for participants to assist with the cost of travel and accommodations (economy airfare, ground transportation, and up to 2 hotel nights) to attend the USDeN annual meeting and junior investigator intensive workshop on May 11, 2022, in Orlando, FL in conjunction with the AGS annual meeting. If you were already planning to attend AGS and have alternative sources of travel support, we ask that you use these first, but if attending the meeting would otherwise be financially burdensome, we encourage you to apply. Requests for support will not affect review of your application to participate in the junior investigator intensive program. 

  • Browse Files
    Cancelof
  • Browse Files
    Cancelof
  • For questions please contact: admin@deprescribingresearch.org

    The US Deprescribing Research Network is supported by a grant from the National Institute on Aging (R24AG064025).

  • Should be Empty: